EQT Fund Management S.a r.l.

Position in OCS — Oculis Holding AG

CIK 1834239 LUXEMBOURG, N4

Position in OCS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$156,888,817

+$39,059,946 QoQ

Shares Held

5,900,294

0.0% QoQ

Ownership

9.77%

of shares outstanding

% of Portfolio

15.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

EQT Fund Management S.a r.l. holds $420,905,779 across 4 Biotechnology names. OCS ranks #1 (37.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	OCS	Oculis Holding AG This page	5,900,294	$156,888,817
2	EVMN	Evommune, Inc.	4,929,633	$113,332,262
3	PHVS	Pharvaris N.V.	3,424,609	$96,745,204
4	AGMB	Agomab Therapeutics NV	5,141,992	$53,939,496

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$156,888,817	5,900,294	0.0%	Shares	Sole	2026-05-14
2025-12-31	$117,828,871	5,900,294	0.0%	Shares	Sole	2026-02-11
2025-09-30	$103,727,168	5,900,294	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.